Results 31 to 40 of about 32,416 (217)
Gli autori descrivono le caratteristiche del vaccino anti-pneumococcico polisaccaridi, ponendo una particolare attenzione alla sua efficacia e tollerabilità nella popolazione anziana.
D'ALESSANDRO, Daniela, Y. Kodra
openaire +6 more sources
Pneumococcal vaccine and opsonic pneumococcal antibody [PDF]
Streptococcus pneumoniae is a major human pathogen responsible for the majority of bacterial pneumonia cases as well as invasive pneumococcal diseases with high mortality and morbidity. Use of conjugate vaccines targeting the pneumococcal capsule has dramatically reduced the incidence of invasive diseases, and there are active efforts to further ...
Joon Young, Song +3 more
openaire +2 more sources
Should Pneumococcal Vaccines Eliminate Nasopharyngeal Colonization?
Streptococcus pneumoniae remains an important human pathogen. For more than 100 years, there have been vaccine efforts to prevent pneumococcal infection. The pneumococcal conjugate vaccines have significantly reduced invasive disease.
Larry S. McDaniel, Edwin Swiatlo
doaj +1 more source
Objectives: Budgetary constraints force healthcare authorities to set priorities for optimal vaccine interventions. A comprehensive decision-making tool would help inform the best combination and sequence of introduction of vaccines within constrained ...
Chun-Yi Lu +4 more
doaj +1 more source
The remarkable history of pneumococcal vaccination: an ongoing challenge
Although it varies with age and geographical distribution, the global burden of infection with Streptococcus pneumoniae (pneumococcus) remains considerable.
Daniel M. Musher +2 more
doaj +1 more source
Relevance. In 2007, WHO recommended pneumococcal conjugate vaccines (PCV) be included in national immunization schedules for young children. By 2020, 145 countries, including Russia, were using PCV. Aims.
N. N. Kostyukova, V. A. Bekhalo
doaj +1 more source
Streptococcus pneumoniae continues to take a heavy toll on childhood mortality and morbidity across the developing world. An estimated 10.6 million invasive pneumococcal diseases (IPDs) occur every year, with nearly 1 million deaths in children under 5 years of age. Introduction of vaccines in the childhood immunisation programme in developed world has
Anand, Manoharan, Ranjith, Jayaraman
openaire +2 more sources
Trends in incidence of pneumococcal disease before introduction of conjugate vaccine: South West England, 1996-2005. [PDF]
Introduction of pneumococcal conjugate and polysaccharide vaccines into the United Kingdom's routine immunization programmes is expected to change the epidemiology of invasive pneumococcal disease (IPD).
Dance, DA +21 more
core +1 more source
Monitoring the introduction of pneumococcal conjugate vaccines into West Africa: design and implementation of a population-based surveillance system. [PDF]
Routine use of pneumococcal conjugate vaccines (PCVs) in developing countries is expected to lead to a significant reduction in childhood deaths. However, PCVs have been associated with replacement disease with non-vaccine serotypes.
Greenwood, Brian M +55 more
core +1 more source
Decrease in Pneumococcal Co-Colonization following Vaccination with the Seven-Valent Pneumococcal Conjugate Vaccine [PDF]
Understanding the epidemiology of pneumococcal co-colonization is important for monitoring vaccine effectiveness and the occurrence of horizontal gene transfer between pneumococcal strains.
Sá-Leão, Raquel +32 more
core +1 more source

